| 8. April 2026 |
11:30 |
Early-life microbiota: Programming immunity and disease
Flyer |
Dr. Ziad Al Nabhani
Assistant Professor, ERC-StGfellow, Department of Visceral Surgery and Medicine, Bern University Hospital (Inselspital)
Department for Biomedical Research, University of Bern |
C. Bourquin |
| 18. März 2026 |
11:30 |
An introduction to the Department of Digital Medicine and a real-life AI implementation in pathology
Flyer |
Prof. Inti Zlobec
Director of the Department of Digital Medicine (DDM), University of Bern
Dr. Amjad Khan
Research associate Department of Digital Medicine (DDM), University of Bern |
C. Bourquin |
| Sept 18, 2025 |
10:15 |
Federated lipidomics of human blood plasma |
Dr. Markus R. Wenk, Dean College of Health & Life Sciences
Hamad Bin Khalifa University, Qatar |
M. Masoodi |
| Aug 28, 2025 |
11:00 |
Donor-derived cell-free DNA for personalized
immunosuppression in transplantation |
Prof. Dr. med. Dr. h.c. Michael Oellerich, Georg-August University Göttingen, Germany |
U. Amstutz |
| April 30, 2025 |
11:30 |
Antibody delivery strategies promoting neuronal plasticity in the central nervous system |
Prof. Vincent Pernet, Associate professor of neuroscience at the
University of Bern, Research group leader at the Center for experimental
neurology (ZEN), department neurology of the Inselspital, Bern
Adjunct
Professor at the department of molecular medicine of the University
Laval, Quebec City, Canada. |
C. Bourquin |
Dec 05, 2024
|
16:00 |
mRNA applications for cancer immuno therapy at BioNTech |
Dr. Christian Hotz, Senior Director at BioNTech |
C. Bourquin |
Nov 27, 2024
|
12:00 |
The Interplay Between Analytics and Biology for Biomedical Research |
Dr. Juan Zhang, Associate Director, Novartis Institutes for Biomedical Research, Basel |
V. van der Velpen |
| July 9, 2024 |
11:00 |
Cardiovascular Toxicity in Chronic Therapies: The Role of P2X7 Receptors in Health and Disease |
Dr. Collado Diaz Victor, Institute of Pharmaceutical Sciences, ETH Zurich |
G. Konstantinidou |
Mar 6, 2024
|
12:15 |
Pharmacometabolomics guided by breath analysis |
Prof. Dr. Pablo Sinues, University Children's Hospital Basel, University of Basel, Basel |
V. van der Velpen |
Nov 15, 2023
|
12:15 |
News in cellular Ca2+ signalling by sphingosine 1-phosphate |
Prof. Dr. med. Dagmar Meyer zu Heringdorf, Pharmazentrum Frankfurt, Frankfurt am Main |
A. Huwiler
|
Nov 1, 2023
|
12:15 |
N-Acetyl-L-Leucine: A symptomatic drug with neuroprotective potential? |
PD Dr. med. Tatiana Bremova-Ertl, Universitätsklinik für Neurologie, Inselspital, Bern |
A. Huwiler
|
Oct 25, 2023
|
12:15 |
Proteins and missense mutations in health and disease |
Prof. Dr. Özlem Tastan Bishop, Research Unit in Bioinformatics (RUBi), Department of Biochemistry and Microbiology, Rhodes University, Grahamstown/Makhanda, 6139, South Africa |
C. Largiadèr |
Oct 18, 2023
|
12:15 |
Lipid metabolism regulates ferroptosis in lung cancer |
Prof. Dr. med. Pier Paolo Scaglioni, Division of Hematology Oncology, University of Cincinnati, USA |
G. Konstantinidou
|
Oct 11, 2023
|
12:15 |
N-Acetyl-L-Leucine: A symptomatic drug with neuroprotective potential?
|
PD Dr. med. Tatiana Bremova-Ertl, Universitätsklinik für Neurologie, Inselspital, Bern |
A. Huwiler
|
Sept 14, 2023
|
13:30 |
Metabolome and exposome in metabolic dysfunction associated steatotic liver disease. Place: Microscopy- lecture hall, Pathology |
Prof. Matej Orešič, Örebro University, Sweden |
M. Masoodi
|
June 22, 2023
|
12:15 |
SLC Atlas: towards a unified view
|
Dr. Gergely Gyimesi, Department of Biomedical Research/Nephrology, University of Bern |
A. Huwiler
|
Mar 15, 2023
|
12:15 |
Solute carriers in metabolism and (auto)immunity: molecular mechanisms and therapeutic potential |
Prof. Dr. Manuele Rebsamen, Department of Immunobiology, University of Lausanne |
G. Konstantinidou |
Mar 14, 2'23
|
12:15 |
How does the tumour suppressor p53 prevent the development of cancer? |
Prof. Dr. Andreas Strasser, The Walter and Eliza Hall Institute of Medical Research (WEHI), Melbourne, Australia |
T. Kaufmann
|
Feb 28, 2023
|
14:00 |
Non-canonical roles for long and fragile genes in cancer and neuropathologies |
Prof. Rami Aqeilan, Lautenberg Center for Immunology and Cancer Research, Hebrew University – Hadassah Medical School, Jerusalem, Israel |
H-U Simon
|
Feb 1, 2023
|
12:15 |
Cellular roles and molecular mechanisms of acid-sensing ion channels |
PD Dr. Stephan Kellenberger, Department of Biomedical Sciences, University of Lausanne |
A. Huwiler
|
| Jan 18, 2023 |
12:15 |
Why one drug is not enough? |
Prof. Dr. Patrycja Nowak-Sliwinska, Institute of Pharmaceutical Sciences, University of Geneva |
G. Konstantinidou |
| Dec 19, 2022 |
12:15 |
Targeting the tumor stroma: new concepts and potential approaches |
Dr. Anna Brichkina, Center for Tumor Biology and Immunology, Philipps University of Marburg, Germany |
H-U Simon |
Oct 12, 2022
|
12:15 |
Multifaceted roles of the E3 Liagase TRIM25 in colorectal cancer
|
Prof. Dr. Wolfgang Eberhardt, Pharmazentrum Frankfurt/ZAFES, Goethe University Frankfurt am Main |
A. Huwiler
|
Sept 21, 2022
|
12:15 |
Predictive potential of the integration of multi-source molecular data and imaging-based radiomic data in (experimental) fibrosing ILD |
Prof. Dr. med. Britta Maurer, Universitätsklinik für Rheumatologie und Immunologie, Inselspital, Bern |
S. von Gunten |
July 6, 2022
|
12:15 |
Integrin targeting pharmacology – The mechanism of action matter |
Priv. Doz. Dr. Gabriele Weitz-Schmidt, AlloCyte Pharmaceuticals AG, Basel |
A. Huwiler
|
April 13, 2022
|
12:15 |
METworks - at the interface between radioresistance and behavior |
Dr. Michaela Medova, Department for BioMedical Research, University of Bern |
G. Konstantinidou |
Jan 19, 2022
|
12:15 |
RNA modifications and disease: Cause or cure? |
Prof. Dr. Sebastian Leidel, Department of Chemistry, Biochemistry and Pharmaceutical Sciences, University of Bern |
A. Huwiler
|
